Dr. Kevin Campbell is an assistant professor of medicine in the Department of Urology at the University of Florida College of Medicine. Dr. Campbell specializes in men’s health, including fertility management, hypogonadism and testosterone therapy, and the treatment of Peyronie’s disease. His clinical interests also include erectile dysfunction, male prosthetic urology and sexual disorders, as well as medical and surgical management of benign prostatic hyperplasia.
His research interests focus on male reproductive solutions involving restoration of sperm production after hormonal or medical suppression.
Areas of Expertise (10)
Benign Prostatic Hyperplasia
Male Posthetic Urology
Evaluating the Utility of Using Text Messages to Communicate With Patients During the COVID-19 PandemicJournal of the American Academy of Orthopaedic Surgeons.
Kevin J. Campbell, et al.
We evaluated the use of text messages to communicate information to patients whose surgeries were postponed because of the COVID-19 restriction on elective surgeries. Our hypothesis was that text messaging would be an effective way to convey updates.
Combination Therapies for Erectile Dysfunction—A Synergy of Modalities Holds the KeyJAMA Network
John F. Sullivan, Kevin J. Campbell and Larry I. Lipshultz
The systematic review and meta-analysis by Mykoniatis et al1 compared the literature on combination therapy vs monotherapy for the treatment of erectile dysfunction (ED). The authors found that combination therapy with phosphodiesterase type 5 (PDE5) inhibitors in conjunction with other accepted treatment modalities, including tadalafil, low-intensity extracorporeal shockwave therapy (Li-ESWT), vacuum erectile device, or antioxidants, was associated with statistically significant improvements in symptoms as measured by the International Index of Erectile function (IIEF) score, with no increase in adverse effects.